首页> 外文OA文献 >1774. Ridinilazole (RDZ) for Clostridium difficile infection (CDI): Correlation of In Vitro Spectrum of Activity with Human Gut Microbiome Profiles from a Phase 2 Clinical Trial

【2h】

1774. Ridinilazole (RDZ) for Clostridium difficile infection (CDI): Correlation of In Vitro Spectrum of Activity with Human Gut Microbiome Profiles from a Phase 2 Clinical Trial

机译：1774.牛唑（RDZ）对于梭菌腹菌性感染（CDI）：来自2期临床试验的人体肠道微生物谱的活性体外谱的相关性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Richard Vickers; Ellie J C Goldstein; Diane Citron; David Snydman; Cheleste M Thorpe; Anne V Kane;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Enteric microbiome profiles during a randomized Phase 2 clinical trial of surotomycin versus vancomycin for the treatment of Clostridium difficile infection [J] . Kristine Cannon The Journal of Antimicrobial Chemotherapy . 2017,第12期

机译：肠道微生物谱期间的肠霉素在随机霉素与万向霉素治疗梭菌性感染的临床试验期间
2. In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection [J] . ChiltonC.H., CrowtherG.S., BainesS.D., The Journal of Antimicrobial Chemotherapy . 2014,第3期

机译：cadazolid对临床上相关的艰难梭菌分离物的体外活性以及在艰难梭菌感染的体外肠道模型中
3. Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin [J] . Snydman David R., McDermott Laura A., Thorpe Cheleste M., The Journal of Antimicrobial Chemotherapy . 2018,第8期

机译：来自啶唑（SMT19969）和万古霉素的2阶段临床试验的蛋白质腹菌分离株的抗菌易感性和核糖型
4. Development of a Vaccine Against Clostridium difficile Infection (CDI): Design, Purification, and Biological Activities of the Recombinant Toxin 1 Antigens [C] . Jerzy Karczewski Vaccine technology IV . 2012

机译：针对艰难梭菌感染（CDI）疫苗的开发：重组毒素1抗原的设计，纯化和生物活性。
5. Use of Shotgun Metagenomic Sequencing to Determine How the Human Gut Microbiome and Antibiotic Resistome Influence the Risk of Recurrent Clostridioides difficile Infection [D] . ?Correa, Maria Alexandra 2020

机译：使用霰弹枪偏测元素测序以确定人体肠道微生物组和抗生素抵抗如何影响复发性梭氧化物差异感染的风险
6. 1774. Ridinilazole (RDZ) for Clostridium difficile infection (CDI): Correlation of In Vitro Spectrum of Activity with Human Gut Microbiome Profiles from a Phase 2 Clinical Trial [O] . Richard Vickers, Ellie J C Goldstein, Diane Citron, -1

机译：1774.利迪尼唑（RDZ）用于艰难梭菌感染（CDI）：体外活性谱与人类肠道微生物组谱的2期临床试验的相关性
7. 668. Quality of Life Changes in Patients with Clostridium difficile Infection (CDI): A Randomized, Double-Blind Trial of Ridinilazole (RDZ) Compared with Vancomycin (VAN) [O] . Sumita Paul, Richard Vickers, Kevin W Garey 2019

机译：668.梭菌性艰难感染患者的生活质量变化（CDI）：与万古霉素（VAN）相比，ridinilazole（RDZ）的随机，双盲试验

1774. Ridinilazole (RDZ) for Clostridium difficile infection (CDI): Correlation of In Vitro Spectrum of Activity with Human Gut Microbiome Profiles from a Phase 2 Clinical Trial

著录项

引文网络

相似文献

相关主题

期刊订阅